drugset / Trial / NCT00002774
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
RandomizedParallel-groupTreatment
Summary
PURPOSE: Randomized phase 2 trial to compare the effectiveness of chemo-radiation therapy (RT + cisplatin + 5-FU) with or without tirapazamine for the treatment of patients with stage III or IV squamous cell carcinomas of the head and neck cancer (SCCHN). RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. Radiation therapy uses high-energy x-rays to damage tumor cells. Tirapazamine may increase the effectiveness of chemotherapy and radiation therapy by making tumor cells more sensitive to therapy.
Timeline
- Start
- 1996-06
- Primary completion
- 2000-06
- Completion
- 2005-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | tirapazamine | Small molecule | 160 mg/m2 | Other |
| Subject | tirapazamine | Small molecule | 220 mg/m2 | Other |
| Subject | tirapazamine | Small molecule | 260 mg/m2 | Other |
| Background | Cisplatin | Other / unclassified | 20 mg/m2 | Intravenous |
| Background | fluorouracil | Small molecule | 600 mg/m2 | Other |